I remember that also, i remember being a little upset that
I remember that also, i remember being a little upset that it sounded like whatever trial we did do for Nash would only lead to another in order to prove the concept. I thought the first trial would do that. my guess is that the conversation started with the first trial and the potential partners said do more and then we will talk. I don't understand this as it seems Nash drugs get rolling on a lot les than what Leronlimab already has. Lets keep in mind the safety aspects are done - other drugs have to prove efficacy and safety.
I don't think partnerships, licenses and buyout talks are very near term, the quietness to me is just quietness. Antonio is not pushing anything and the BOD is just being excessively safe in the eyes of the SEC and FDA. Investors should demand more for there investment in this company as we are wasting time. It could be deals are eminent, however i will believe it when i see it. One the other hand, nobody has predicted anything correctly for years with this company so who knows, my guess is just that.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Toyota's Commitment to Supporting Pediatric Health Initiatives Toyota Motor North America (TMNA) has taken an important step in its commitment to community health by announcing a new round of funding from its Way Forward Fund. This initiative focuses on improving access to crucial care and recovery support for families, with a significant emphasis on children impacted by...
Continue Reading
Teleflex’s Strategic Separation Plan Teleflex Incorporated (NYSE: TFX) is poised to undergo a significant transformation by separating into two independent publicly traded companies, aimed at sharpening focus and enhancing operational efficiency. This bold move is set to reshape the future of the company and leverage distinct business opportunities within the healthcare...
Continue Reading
Rackspace Technology Prepares for First Quarter Earnings Release Rackspace Technology (NASDAQ: RXT), known for its cutting-edge hybrid cloud and artificial intelligence solutions, has exciting news regarding its financial performance. The company is all set to unveil its earnings for the first quarter of 2025 on May 8, 2025, after market closure. CEO Amar Maletira and CFO...
Continue Reading
Recap of the Financial Street Forum 2025 Recently, the Annual Conference of Financial Street Forum traded insights with discussions focused on resilience amid global economic shifts. International Collaboration Participants from various countries engaged in meaningful conversations regarding the current global investment landscape. These discussions helped share financial...
Continue Reading
QHSLab Introduces Q-Cog™ for Early Cognitive Impairment Detection Recent developments in digital health technology have paved the way for more accessible screening options. QHSLab Inc. (OTCQB: USAQ) has taken a significant step forward by launching Q-Cog™, a comprehensive and innovative cognitive assessment tool. This cloud-based platform is tailored to assist primary...
Continue Reading
